betamethasone dipropionate 0.643 MG/ML / calcipotriene 0.05 MG/ML Topical Foam [Enstilar]
RxNorm concept 1716099, branded drug (sbd). Prescribable name: Enstilar 0.005 % / 0.064 % Topical Foam.
- RxCUI
- 1716099
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1716099 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Enstilar (calcipotriene 0.005 % / betamethasone dipropionate 0.064 % ) Topical Foam; Enstilar 0.005 % / 0.064 % Topical Foam
Related concepts
- calcipotriene 0.05 MG/ML (SCDC, consists of)
- betamethasone dipropionate 0.643 MG/ML (SCDC, consists of)
- betamethasone dipropionate 0.643 MG/ML / calcipotriene 0.05 MG/ML [Enstilar] (SBDC, consists of)
- Topical Foam (DF, has dose form)
- Enstilar (BN, has ingredient)
- betamethasone dipropionate 0.643 MG/ML / calcipotriene 0.05 MG/ML Topical Foam (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1716099 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1716099 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1716099. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.